Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
J Clin Oncol Hochster et al. 26:3523
Publisher’s Note
The July 20, 2008, article by Hochster et al, entitled, “Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study” (J Clin Oncol 26:3523-3529, 2008) was published online July 17, 2008 with errors.
In Tables 1, 2, 3 and 4, the following abbreviations were incorrectly given and should have been:
TREE, Three Regimens of Eloxatin Evaluation; mFOLFOX6, bolus and infusion fluorouracil and leucovorin with oxaliplatin; bFOL, bolus fluorouracil and low-dose leucovorin with oxaliplatin; CapeOx, capecitabine with oxaliplatin.
In Table 4, the last column heading for the TREE-2 cohort was given as bFOL + Bev, whereas it should have been CapeOx + Bev.
All corrections have been made as of September 16, 2008.
|
